Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-002786-35Phase 3Completed
Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) and anaemia comparing Ferric carboxymaltose (Ferinject) with Placebo (2 arms). Primary endpoints: Peri-operative blood transfusion requirement and Change in haemoglobin levels. Started Sep 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-002786-35.